Cases
Equifax Inc. (EFX)
Corporate Governance / Derivative
Overview
Overview
- Date:
- 1/22/2018
- Case Caption:
- In re Equifax, Inc. Derivative Litigation
- Stock Symbol:
- EFX
- Status:
- Pending
- Court:
- U.S. District Court: Northern Georgia
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Equifax, Inc. (NASDAQ: EFX) on behalf of long-term stockholders. Our investigation concerns whether the board of directors of Equifax has breached their fiduciary duties to the company.
On September 7, 2017, after market close, Equifax announced a cybersecurity incident potentially impacting approximately 143 million U.S. consumers. According to an Equifax press release, criminals exploited a U.S. website application vulnerability to gain access to certain files, and, based on the company’s investigation, the unauthorized access occurred from mid-May through July 2017. Equifax further announced that they had discovered the unauthorized access on July 29, 2017.
According to documents filed with the Securities and Exchange Commission, on August 1, 2017 and August 2, 2017, prior to the disclosure of this information, three Equifax executives, John Gamble, Rodolfo Ploder, and Joseph Laughran, sold almost $2 million worth of stock combined.
Following this news, shares of Equifax fell $19.49 per share, or 13.66%, to close at $123.23 per share on September 8, 2017.
On September 7, 2017, after market close, Equifax announced a cybersecurity incident potentially impacting approximately 143 million U.S. consumers. According to an Equifax press release, criminals exploited a U.S. website application vulnerability to gain access to certain files, and, based on the company’s investigation, the unauthorized access occurred from mid-May through July 2017. Equifax further announced that they had discovered the unauthorized access on July 29, 2017.
According to documents filed with the Securities and Exchange Commission, on August 1, 2017 and August 2, 2017, prior to the disclosure of this information, three Equifax executives, John Gamble, Rodolfo Ploder, and Joseph Laughran, sold almost $2 million worth of stock combined.
Following this news, shares of Equifax fell $19.49 per share, or 13.66%, to close at $123.23 per share on September 8, 2017.